Whittier Trust’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-25
Closed -$55 1456
2025
Q2
$55 Hold
25
﹤0.01% 1503
2025
Q1
$28 Sell
25
-290
-92% -$427 ﹤0.01% 1487
2024
Q4
$396 Sell
315
-8
-2% -$20 ﹤0.01% 1519
2024
Q3
$1.1K Hold
323
﹤0.01% 1486
2024
Q2
$1.51K Buy
323
+25
+8% +$141 ﹤0.01% 1447
2024
Q1
$2.21K Hold
298
﹤0.01% 1419
2023
Q4
$3.02K Hold
298
﹤0.01% 1370
2023
Q3
$2.32K Hold
298
﹤0.01% 1452
2023
Q2
$2.45K Hold
298
﹤0.01% 1436
2023
Q1
$2.16K Hold
298
﹤0.01% 1481
2022
Q4
$2.64K Hold
298
﹤0.01% 1460
2022
Q3
$4K Hold
298
﹤0.01% 1476
2022
Q2
$4K Hold
298
﹤0.01% 1470
2022
Q1
$6K Hold
298
﹤0.01% 1418
2021
Q4
$8K Hold
298
﹤0.01% 1344
2021
Q3
$12K Hold
298
﹤0.01% 1217
2021
Q2
$17K Hold
298
﹤0.01% 1183
2021
Q1
$13K Hold
298
﹤0.01% 1206
2020
Q4
$21K Hold
298
﹤0.01% 1033
2020
Q3
$8K Hold
298
﹤0.01% 1159
2020
Q2
$9K Hold
298
﹤0.01% 1078
2020
Q1
$6K Hold
298
﹤0.01% 1184
2019
Q4
$9K Hold
298
﹤0.01% 1139
2019
Q3
$7K Hold
298
﹤0.01% 1190
2019
Q2
$7K Hold
298
﹤0.01% 1113
2019
Q1
$7K Hold
298
﹤0.01% 1103
2018
Q4
$7K Hold
298
﹤0.01% 1137
2018
Q3
$9K Hold
298
﹤0.01% 1052
2018
Q2
$11K Buy
+298
New +$10.6K ﹤0.01% 1012

Other funds holding EDIT

Whittier Trust's EDIT Position: Q3 2025 in Review

Whittier Trust sold out of Editas Medicine (EDIT) in Q3 2025, closing a stake of 25 shares — an estimated $55 sold.

Whittier Trust first reported a position in EDIT in Q2 2018 and held it in 29 quarters. The position peaked at $21K in Q4 2020. 193 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

  • Whittier Trust reported no remaining Editas Medicine position as of Q3 2025 after selling out during the quarter.
  • Whittier Trust sold 25 Editas Medicine shares in Q3 2025, an estimated $55.
  • Whittier Trust first reported a position in Editas Medicine in Q2 2018 and held it in 29 quarters.
  • Whittier Trust's Editas Medicine position peaked at $21K in Q4 2020.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on Whittier Trust's 13F filing for Q3 2025, filed 31 Oct 2025.